Delamanid

德拉马尼

Report date: 2024/11/04 16:56:47
NMEFirst In Class

Base Information

Drug NameDelamanid
Drug Alias Namedelamanid地依麦迪delamanidum地拉玛尼德尔巴 +[8] 
ClassificationSmall molecules > Heterocyclic drugs > Antibiotics
Mechanisms of ActionCell wall inhibitorsEnzymes inhibitors
TargetsEnzymes
Therapy Area/IndicationsHIV InfectionsTuberculosis, PulmonaryExtensively Drug-Resistant Tuberculosis +[5] 
Global Approved IndicationsTuberculosis, PulmonaryTuberculosis, Multidrug-Resistant
Approved Indications in ChinaTuberculosis, Multidrug-Resistant
Original Approved Country/TerritoryEU
Original Approved Date2014/04/27
Country/TerritoryUnited StatesTanzaniaPhilippines +[15] 
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesOtsuka Holdings Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesOtsuka Holdings Co LtdOtsuka Pharmaceutical Co LtdNational Institute Of Allergy And Infectious Diseases (Niaid) +[4] 
Inactive CompaniesOtsuka Pharmaceutical Development & Commercialization IncOtsuka Frankfurt Research Institute Gmbh
Active IndicationsHIV InfectionsTuberculosis, PulmonaryTuberculosis, Multidrug-Resistant +[4] 
Inactive IndicationsExtensively Drug-Resistant Tuberculosis

Other Information

ATC CodeJ04AK06
Related LinksWikipediaDrugBankKEGG